ARA 290 peptide is positioned as a high-purity research compound for advanced preclinical studies. This technical deep dive examines its manufacturing specifications, focusing on HPLC-verified purity exceeding 98% and low endotoxin levels critical for in vitro and in vivo applications. The peptide is synthesized via solid-phase methods under cGMP-compliant facilities, ensuring batch-to-batch consistency. Key quality advantages include rigorous mass spectrometry confirmation and lyophilized formulation for stability. Buyers often face pain points such as inconsistent purity from unverified suppliers or incomplete documentation; this article addresses sourcing certification requirements, including COA and third-party testing reports. By understanding these standards, researchers can mitigate variability risks and select reliable sources for their experimental protocols.
Target Keyword: ara 290
ARA 290 peptide is a synthetic, 11-amino acid peptide derived from the erythropoietin (EPO) helix B domain. It is designed for high-purity research and cosmetic formulation applications, targeting professional buyers in the B2B peptide supply chain, including cosmetic R&D labs, biotech research institutions, and bulk raw material distributors. The core value of ARA 290 lies in its refined molecular structure, which offers enhanced stability and specificity for advanced formulation studies.
Industry data indicates that peptide purity above 98% reduces batch-to-batch variability by 40% in cosmetic formulation trials, directly impacting reproducibility and regulatory compliance.
The production of ARA 290 peptide follows a rigorous solid-phase peptide synthesis (SPPS) protocol, utilizing Fmoc chemistry for precise amino acid coupling. Each batch undergoes multiple purification stages to ensure consistent quality and performance.
SPPS is conducted on automated synthesizers with real-time monitoring of coupling efficiency. After cleavage and deprotection, the crude peptide is purified via preparative HPLC using a C18 column and gradient elution with acetonitrile/water containing 0.1% TFA.
Post-purification, each batch is analyzed by analytical HPLC for purity verification, followed by mass spectrometry (ESI-MS) for molecular weight confirmation. Additional QC includes amino acid analysis and residual solvent testing per ICH guidelines.
ARA 290 peptide is utilized across multiple B2B sectors, each requiring specific purity and handling protocols.
In cosmetic R&D, ARA 290 is incorporated into serum and cream bases at concentrations of 0.1–1.0% for stability and sensory testing. Its high solubility allows for cold-process formulation, reducing thermal degradation risks. Formulators value its consistent batch-to-batch performance for reproducible results.
Academic and biotech labs use ARA 290 in cell culture studies to investigate receptor binding and signaling pathways. The ≥98% purity ensures minimal interference from truncated or oxidized peptide variants, critical for dose-response experiments.
Distributors and contract manufacturers purchase ARA 290 in bulk quantities (1g–100g) for downstream processing or resale. Bulk orders benefit from discounted pricing and customized packaging options, including vacuum-sealed vials or nitrogen-flushed bags for extended stability.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | ≥98% by HPLC | 85–95% by HPLC | Higher purity reduces side reactions and improves formulation consistency |
| Stability | 24 months at -20°C | 6–12 months at -20°C | Extended shelf life lowers inventory risk for bulk buyers |
| Solubility | 10 mg/mL in water | ≤5 mg/mL in water | Higher solubility enables concentrated formulations without precipitation |
| Certification | Full COA, MSDS, stability data | Limited or no documentation | Complete traceability supports regulatory audits and quality assurance |
When sourcing ARA 290 peptide in bulk, buyers must navigate common pitfalls to ensure product quality and supply chain reliability.
Low-cost suppliers often offer peptides with purity below 95%, which can contain truncated sequences or residual solvents. Without proper COA documentation, these impurities may compromise research outcomes or formulation stability. Additionally, inadequate packaging leads to moisture absorption and peptide degradation during transit.
Our ARA 290 peptide offers distinct benefits for B2B buyers seeking reliable raw materials for research and formulation.
Purity: Each batch is tested by HPLC and mass spectrometry, guaranteeing ≥98% purity with full traceability. This eliminates variability in experimental results and formulation performance.
Stability: Lyophilized powder remains stable for 24 months under recommended storage, reducing waste and enabling long-term inventory planning. Accelerated stability data confirms consistent potency over time.
Cost Performance: Competitive bulk pricing without compromising quality, supported by direct manufacturing and streamlined supply chains. Volume discounts are available for orders above 5g.
Technical Support: Our team provides formulation guidance, solubility optimization, and custom packaging options to meet specific project requirements. All inquiries receive a response within 24 hours.
Q1: What is the minimum purity required for cosmetic formulation use of ARA 290 peptide?
For cosmetic formulations, a minimum purity of 98% is recommended to ensure consistent product performance and minimize the risk of impurities that could affect formulation stability or sensory properties. Higher purity grades (≥99%) are available for more sensitive applications.
Q2: How should ARA 290 peptide be stored after reconstitution?
After reconstitution in sterile water or PBS, the solution should be stored at 4°C and used within 7 days. For longer storage, aliquot and freeze at -20°C for up to 30 days. Avoid repeated freeze-thaw cycles to maintain peptide integrity.
Q3: Can ARA 290 peptide be used in combination with other peptides in a single formulation?
Yes, ARA 290 is compatible with many common peptides used in cosmetic formulations. However, compatibility testing is recommended to confirm no precipitation or degradation occurs. Our technical team can provide guidance on formulation optimization.